Nancy J Roizen1, Caroline I Magyar2, Emily S Kuschner3, Steven B Sulkes2, Charlotte Druschel4, Edwin van Wijngaarden5, Lisa Rodgers2, Alison Diehl2, Richard Lowry6, Susan L Hyman2. 1. Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH. 2. Department of Pediatrics, University of Rochester School of Medicine, Rochester, NY. 3. Center for Autism Research, Children's Hospital of Philadelphia, Philadelphia, PA. 4. New York Congenital Malformations Registry, New York State Department of Health, Albany, NY; University of Albany School of Public Health, Rensselear, NY. 5. Department of Public Health, University of Rochester School of Medicine, Rochester, NY. 6. Department of Psychology, Vassar College, Poughkeepsie, NY.
Abstract
OBJECTIVE: To determine the frequency of medical problems in a large population of children with Down syndrome. STUDY DESIGN: Study population included 440 children with Down syndrome (ages 3-14 years) identified primarily through the New York Congenital Malformations Registry. Parents completed questionnaires on medical problems. RESULTS: Our study population was predominately White (92.3%), non-Hispanic (72.3%) with at least 1 college educated parent (72.3%). The prevalence of medical problems was as follows: heart disease (55%), hearing problem (39%), vision problem (39%), thyroid disease (27%), celiac disease (5%), alopecia (5%), seizures (7%), asthma/reactive airway disease (32%), diabetes (1%), and juvenile rheumatoid arthritis (0.2%). Of the children with heart disease, 58% needed surgery at a mean age of 9 months. Of the children with hearing loss, 29% were identified on newborn screening and 13% used an amplification device. Of the children with thyroid disease, 31% were diagnosed in the newborn period. Only 7% of these children with Down syndrome had no medical problem listed. CONCLUSION: Prevalence data of medical illnesses in a large population of children with Down syndrome provide us with data to support implementation of the American Academy of Pediatrics guidelines for health supervision for children with Down syndrome. The long-term health implications of the conditions we surveyed will be important for decreasing morbidity and increasing overall health and wellness into adulthood.
OBJECTIVE: To determine the frequency of medical problems in a large population of children with Down syndrome. STUDY DESIGN: Study population included 440 children with Down syndrome (ages 3-14 years) identified primarily through the New York Congenital Malformations Registry. Parents completed questionnaires on medical problems. RESULTS: Our study population was predominately White (92.3%), non-Hispanic (72.3%) with at least 1 college educated parent (72.3%). The prevalence of medical problems was as follows: heart disease (55%), hearing problem (39%), vision problem (39%), thyroid disease (27%), celiac disease (5%), alopecia (5%), seizures (7%), asthma/reactive airway disease (32%), diabetes (1%), and juvenile rheumatoid arthritis (0.2%). Of the children with heart disease, 58% needed surgery at a mean age of 9 months. Of the children with hearing loss, 29% were identified on newborn screening and 13% used an amplification device. Of the children with thyroid disease, 31% were diagnosed in the newborn period. Only 7% of these children with Down syndrome had no medical problem listed. CONCLUSION: Prevalence data of medical illnesses in a large population of children with Down syndrome provide us with data to support implementation of the American Academy of Pediatrics guidelines for health supervision for children with Down syndrome. The long-term health implications of the conditions we surveyed will be important for decreasing morbidity and increasing overall health and wellness into adulthood.
Authors: Babette S Zemel; Mary Pipan; Virginia A Stallings; Waynitra Hall; Kim Schadt; David S Freedman; Phoebe Thorpe Journal: Pediatrics Date: 2015-11 Impact factor: 7.124
Authors: Karen L Baab; Peter Brown; Dean Falk; Joan T Richtsmeier; Charles F Hildebolt; Kirk Smith; William Jungers Journal: PLoS One Date: 2016-06-08 Impact factor: 3.240
Authors: Anna Nicek; Nasreen Talib; Daniel Lovell; Chelsey Smith; Mara L Becker; Jordan T Jones Journal: Pediatr Rheumatol Online J Date: 2020-07-13 Impact factor: 3.054
Authors: Borja Suarez-Villadat; Ariel Villagra; Oscar L Veiga; Veronica Cabanas-Sanchez; Rocio Izquierdo-Gomez Journal: Int J Environ Res Public Health Date: 2021-05-21 Impact factor: 3.390
Authors: Carla M Startin; Hana D'Souza; George Ball; Sarah Hamburg; Rosalyn Hithersay; Kate M O Hughes; Esha Massand; Annette Karmiloff-Smith; Michael S C Thomas; Andre Strydom Journal: J Neurodev Disord Date: 2020-01-23 Impact factor: 4.025